Abstract |
In the present study are reported the differential DNA binding activity of the anti- tumor polyamidine tetra-p-amidinophenoxyneopentane ( TAPP-H) and its 2'-halo derivative ( TAPP-Br), and their effects on the binding of the recombinant Epstein-Barr virus ( EBV) nuclear antigen to a synthetic oligonucleotide mimicking the target DNA sequence present in the EBV genome. In addition, the proliferation kinetics and cell cycle analysis of human leukemia K562 cells treated with TAPP-H and TAPP-Br are reported. The possible in vivo relationship between DNA binding affinity and cytotoxicity is also discussed.
|
Authors | C Nastruzzi, E Menegatti, C Pastesini, R Cortesi, E Esposito, M Spano, R Biagini, E Cordelli, G Feriotto, R Gambari |
Journal | Biochemical pharmacology
(Biochem Pharmacol)
Vol. 44
Issue 10
Pg. 1985-94
(Nov 17 1992)
ISSN: 0006-2952 [Print] England |
PMID | 1449517
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Viral
- Benzamidines
- DNA, Viral
- DNA-Binding Proteins
- Epstein-Barr Virus Nuclear Antigens
- 1,3-di-(4-amidinophenoxy)-2,2-bis-(4-amidinophenoxymethyl)propane
- 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide
- diminazene aceturate
- Diminazene
|
Topics |
- Antigens, Viral
(chemistry, metabolism)
- Base Sequence
- Benzamidines
(pharmacology)
- Cell Cycle
- Cell Division
(drug effects)
- DNA, Viral
(metabolism)
- DNA-Binding Proteins
(chemistry, metabolism)
- Diminazene
(analogs & derivatives, pharmacology)
- Dose-Response Relationship, Drug
- Epstein-Barr Virus Nuclear Antigens
- Humans
- Molecular Sequence Data
- Tumor Cells, Cultured
(drug effects)
|